Lung cancer causes more deaths than any other cancer, both in the United States and worldwide, in men and women alike. One in 13 men and 1 in 16 women will develop lung cancer. Each year, about 200,000 Americans are diagnosed with and another 150,000 Americans die of lung cancer.
The award-winning Oncology Center of Excellence at Connexion Healthcare communicates relevant, evidence-based, scientific information about cancer. Connexion Healthcare is also helping to spread the message about what you can do to lower your risk of getting lung cancer.
How Can I Lower My Risk of Lung Cancer?
- Do not start smoking. If you do smoke, quit.
- Cigarette smoking is linked to 90% of lung cancers.
- Tobacco smoke contains more than 4,000 chemical compounds, many of which are carcinogenic.
- Avoid secondhand smoke, because it’s just like smoking when you breathe it in.
- Each year, secondhand smoke kills 7,300 American with lung cancer who never smoked.
- Nonsmokers who live with smokers have a 24% increased risk of lung cancer.
- Get your home tested for radon.
- The second leading cause of lung cancer is radon.
- Radon is a naturally occurring radioactive gas that you cannot smell, taste, or see, but that can be trapped in homes and other buildings.
What Other Factors Increase the Risk of Lung Cancer?
- Occupation (eg, asbestos exposure, mining industry)
- Radiation exposure
- Other illnesses (eg, tuberculosis, chronic obstructive pulmonary disease)
- Family history
What Is Lung Cancer, Exactly?
Lung cancer is the uncontrolled growth of abnormal cells in the lung that eventually
form tumors and interfere with lung function. Lung tumors are not usually found in the
early stages of the disease. This is because the lungs are large organs, which make it possible for tumors to grow in them for a long time before symptoms occur. Even when symptoms do occur, they are usually attributed to other causes.
The 2 major types of lung cancer are non-small cell lung cancer (NSCLC) and small cell
lung cancer (SCLC).
NSCLCs account for about 85% of lung cancers in the United States, and consist of:
- Adenocarcinomas – the most common type
- Squamous cell carcinomas (also called epidermoid carcinomas) – these form in the lining of the bronchial tubes
- Large cell carcinomas – these are neither adenocarcinomas nor epidermoid carcinomas
SCLCs, which account for the remaining 15% of lung cancers in the United States:
- Result from smoking, even more so than NSCLCs
- Grow more rapidly and spread to other parts of the body earlier than NSCLCs, but are more responsive to chemotherapy
What Symptoms of Lung Cancer Should I Look For?
Think “B R E A T H E.” See your doctor if you have any of these symptoms:
B: Blood when you spit or cough
R: Respiratory infections that recur
E: Enduring cough that is different or new
A: Aches or pain in the back, chest, shoulder
T: Trouble breathing
H: Hoarseness, wheezing
E: Exhaustion, loss of appetite, weakness
November is dedicated to increasing the understanding of lung cancer, including its prevalence, screening, prevention, and treatment. Please join us in spreading this message to help raise awareness.
About the Connexion Healthcare Oncology Center of Excellence
Connexion Healthcare is a full-service global provider of strategic medical and scientific communications with decades of experience providing exceptional service to the pharmaceutical industry. We provide services through 2 Centers of Excellence—Oncology and Rare Disease—and possess core expertise in these therapeutic areas and their marketplaces.
Connexion Healthcare’s Oncology Center of Excellence offers executive talent with decades of experience in the pharmaceutical industry. Our medical directors have conducted oncology research at leading institutions and major pharmaceutical companies. Our account leads have years of project execution expertise, and our medical writers and editors are versed in the language of oncology. Our design leads are tops in their fields and ensure that your objectives are met effectively and even surpassed in an industry-eloquent and compliant manner. Our team works with you to conceive a strategy and execute communications through your product’s lifespan – from drug discovery through market launch and beyond. With particular expertise in phase 2 through postlaunch, we will engage with you wherever you are in development and whenever you need us.
For further information regarding the Oncology Center of Excellence at Connexion Healthcare and how we can develop oncology communications to differentiate therapies by their unique attributes, contact:
Senior Vice President, Oncology
Val Sudakin, PhD
Vice President, Hematology/Oncology Scientific Services